Skip to content

ALTERITAM

Active
Private limited company·Activiteiten van huisartspraktijken· 4 yrs active
de Villegaslaan 5 ·1083 Ganshoren, Belgium
KBO/BCE: BE 0778.936.031
Watch Print / PDF
Age4 yrs

Summary

Conclusion

the dossier summarised in one paragraph

The computed 12-month bankruptcy probability of ALTERITAM is 0.7% (low). The 2024 annual accounts show negative equity (€-3k) and a net result of €-9k. Equity is shrinking by ~85% per year across the filed fiscal years. Its solvency ranks better than 5% of 6582 sector peers (fiscal year 2024). The company has been active since 2021 and the Belgian State Gazette contains no insolvency or warning signals.

Based on the State Gazette, CBE and 3 annual accounts.

Bankruptcy probability (12 mo)

Checked model v1 · free for everyone
0.7% Low
0%0,5%1,5%4%10%≥25%
Lower-failure-rate sector Young company +Annual accounts: weaker financial profile +

Statistical estimate based on public sources, not credit advice nor a finding of fact. How do we compute this?

Signals

1 signal · with evidence
Negative equity
Equity is negative for financial year 2024: liabilities exceed assets. This is the trigger point of the alarm-bell procedure (Belgian CAC).
View the annual accounts

Signals are derived from the filed annual accounts and the sector comparison. No composite score: each signal is separately verifiable at the source.

Filing behaviour

From the deposit records, complete market-wide
Deadline passed, not yet counted as missing
The deadline for the year that closed on 31-12-2025 passed on 31-07-2026, 15 days ago. Our copy of the deposit register trails the National Bank (measured: median 14 days, p99 45 days), so we only call this filing missing from 45 days past the deadline.
Filed more than 90 days late
The financial year that closed on 31-12-2024 was due by 31-07-2025 and was filed on 11-02-2026, 195 days past the deadline. Measured on financial year 2023: companies more than 90 days late are in an abnormal legal state today in 5.61% of cases, against 1.66% across all filers.
How we compute the deadline
The year end is derived from 3 filed financial years, each closing on 31-12. The statutory deadline is seven months after the close of the financial year (art. 3:10 par. 1 CAC, art. 3:47 par. 7 for ASBL and foundations). Applied to the financial year that closed on 31-12-2024, that is 31-07-2025.
Deadline per financial year
Year closed Due by Filed Variance Reference
31-12-2025 31-07-2026 nothing on record not filed -
31-12-2024 31-07-2025 11-02-2026 195 d late 2026-00039994
31-12-2023 31-07-2024 30-09-2024 61 d late 2024-00494269
31-12-2022 31-07-2023 31-01-2024 184 d late 2024-00013385

Source: the National Bank's deposit records. Those records are complete, including for years whose figures we have not read yet. Filing late covers nearly half the market and is therefore not scored; only not filing, being more than 90 days late and breaking a punctual record carry weight.

Trust signals

2 signals
More than 3 years active
Founded in 2021, past the statistically most fragile first 3 years.
No legal incidents
No bankruptcy, reorganisation or interim measure in the Belgisch Staatsblad, and the KBO register records a normal legal situation.

Administrative Flags

No strikeouts found in the KBO publications we processed. That series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.

Financials

TurnoverNot published (abbreviated filing)
EBIT marginNot published (abbreviated filing)
Net result€-9k-2423.5%
Working capital€-13k-271.7%

Annual accounts & ratios

Source: NBB · 2024
Annual accounts filed on 11-02-2026 with the NBB · fiscal year 2024 · micro
€-10k€-5k€0€5kOperating result 2022: €4k€4kNet result 2022: €3k€3kOperating result 2023: €1k€1kNet result 2023: €-339€-339Operating result 2024: €-6k€-6kNet result 2024: €-9k€-9k202220232024
Operating resultNet result
Trajectory (indicative)
Projection over 3 fiscal years from the filed annual accounts, not a forecast, the extended trend.
declining Equity: declining trend of ~85%/year over 3 fiscal years, indicative, assuming unchanged policy.
€-20k€-10k€0€10k2025: €-8k (€-8k - €-8k)2026: €-12k (€-12k - €-12k)2027: €-17k (€-17k - €-16k)2022: €6k2023: €5k2024: €-3k202220232024202520262027
Solid line = filed figures · dashed = extended trend · area = indicative range.
How do we compute this?

The trend is a robust median of all pairwise slopes between fiscal years (Theil-Sen), so a single odd year cannot hijack the line. For strictly positive series we also fit a log variant (compound annual growth) and keep whichever describes the figures best.

The area around the projection is 1.8 × the median absolute deviation from the trend, widening each year ahead (×1 / ×1.6 / ×2.2), with a minimum of 8% of the last value. It is an indicative range, not a statistical confidence interval.

A series whose deviations exceed 35% of its level is too volatile: we then deliberately show no projection. Every projection assumes unchanged policy and is blind to non-public information (order book, contracts, funding rounds).

Sector comparison
Fiscal year 2024 · NACE 86, Human health · compared within the same schema type (micro schema)
Metric This company Sector median Position in the sector
Solvency -32.3% 66.7%
better than 5% of 6582 sector peers
Net result €-9k €46k
better than 5% of 6576 sector peers
Equity €-3k €79k
better than 5% of 6582 sector peers
Gross operating margin €707 €78k
better than 5% of 6584 sector peers
Total assets €10k €154k
better than 5% of 6585 sector peers
Median and position computed from NBB annual accounts filed by sector peers; own figures from the latest filed accounts.
Sector position over time
Percentile per fiscal year versus peers that filed figures, computed year by year (a year without enough peers is absent).
Solvency P5
2022: P26 · n=36842023: P21 · n=53462024: P5 · n=65822022 2024
Weakening position over 2022-2024 · n=3684-6582
Net result P5
2022: P13 · n=36822023: P9 · n=53452024: P5 · n=65762022 2024
Stable position over 2022-2024 · n=3682-6576
Equity P5
2022: P10 · n=36842023: P10 · n=53482024: P5 · n=65822022 2024
Stable position over 2022-2024 · n=3684-6582
Gross operating margin P5
2022: P12 · n=36802023: P8 · n=53422024: P5 · n=65842022 2024
Stable position over 2022-2024 · n=3680-6584
Describes the position versus peers, not a forecast.
EBITDA
€-3k
- 22-24
Net profit
€-9k
-2423.5% 22-24
Cash flow
€-5k
- 22-24
Total assets
€10k
-45.0% 22-24
Equity
€-3k
- 22-24
Working capital
€-13k
-271.7% 22-24
Income taxes
€3k
+192.5% 22-24
Debt
€14k
+0.9% 22-24
Debt ≤ 1y
€14k
+0.9% 22-24
Current ratio
0.08
-89.5% 22-24
Quick ratio
0.08
-89.5% 22-24
Solvency
-32.3%
- 22-24
Debt / equity
-4.10
- 22-24
ROE
257.2%
- 22-24
ROA
-83.0%
-4489.8% 22-24
Interest coverage
-11.70
- 22-24
Figures by fiscal year
Fiscal year2024
Depositmicro
Revenue-
EBITDA€-3k
Net profit€-9k
Cash flow€-5k
Staff costs-
Income taxes€3k
Dividends-
Total assets€10k
Equity€-3k
Debt€14k
of which ≤ 1y€14k
of which > 1y-
Working capital€-13k
Employees (FTE)-
Ratios (computed)
2024
Current ratio0.08
Quick ratio0.08
Working capital ratio-121.8%
Solvency-32.3%
Debt / equity-4.10
Long-term debt ratio-
Interest coverage-11.70
Gross margin-
Net margin-
ROA-83.0%
ROE257.2%
EBITDA margin-
Days sales outstanding-
Days payable outstanding-
Inventory turnover-
Days inventory (DSI)-
Balance-sheet composition 2024
Full annual accounts
Filed balance sheet and income statement, exactly as deposited with the NBB.
Line item Code2024
Balance sheet, Assets
TOTAL ASSETS 20/58€10k
Fixed assets 21/28€8k
Formation expenses 20€1k
Tangible fixed assets 22/27€6k
Financial fixed assets 28€2k
Current assets 29/58€1k
Cash & bank 54/58€1k
Balance sheet, Equity & liabilities
TOTAL EQUITY & LIABILITIES 10/49€10k
Equity 10/15€-3k
Contributions / capital 10/11€3k
Accumulated profits (losses) 14€-6k
Amounts payable 17/49€14k
Amounts payable within one year 42/48€14k
Trade debts payable within one year 44€4k
Income statement
Gross operating margin 9900€707
Operating result 9901€-6k
Financial charges 65€216
Result before taxes 9903€-6k
Income taxes 67/77€3k
Net result for the period 9904€-9k
Result to be appropriated 9905€-9k
You are seeing the latest fiscal year only. 2 prior years (figures + ratios) are in a paid plan. See plans →
Ratios computed by Checked.

Health barometer

FY 2024 · computed
7 / 100 Critical
050100
Computed from 5 of the 6 factors this model weighs. The rest cannot be derived from the filed figures, or need a prior year to compare against.

The full score breakdown, per-year score history and the indicative credit limit are in Kantoor S.

See plans →
Computed by Checked from the NBB filing for FY 2024. Indicative, not credit advice.

Structure & network

Locations & real estate

Registered office

from the Crossroads Bank
Cannot be placed on the map

This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.

de Villegaslaan 51083 Ganshoren

Establishment units

1 location
ALTERITAM
Boulevard Dolez 6A, 7000 MonsActiviteiten van huisartspraktijken
since 20212.325.369.815
Physical sites registered in the Crossroads Bank for Enterprises (CBE).
Parcels2
Ground area2,153 m²
Buildings2
Building footprint687 m²
Volume (LiDAR)10,068 m³
Tallest building24.0 m · ±7 fl.

Real-estate footprint

Source: CBE × cadastre · address linking

Parcels linked to this company through its CBE addresses (seat, establishment units, branches), cross-referenced with the cadastral parcel plan. This shows where the company operates, not a deeds register.

Wallonia 1 (50%) Brussels 1 (50%)
Parcel (capakey) Region Area Buildings Height / fl.
53405C0001/00K037 Wallonia 2,025 m² 1 · 641 m² 19.4 m · 5 fl.
21392B0100/00H005
ProtectedMonumentRésidence BasiliqueSource ↗
Brussels 128 m² 1 · 46 m² 24.0 m · 7 fl.
Methodology
via registered seat: 1 · via establishment units: 1
2 of 2 parcels with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
1 of these parcels carry protected heritage (source: regional heritage registers, Onroerend Erfgoed / patrimoine.brussels).

Publications

Lifecycle & Insolvency Signals

No insolvency signals in the Belgian State Gazette

Belgian State Gazette · acts

No structured acts for this company yet

That means one of two things: the company has published no company deeds, or its deeds are still queued for reading. The insolvency signals above come from a separate source; the KBO register is the second source and appears as the legal situation on this page.

Analysis

Snowflake analysis

financial profile on 5 axes
Health7Profitability100Solvency33Growth32Stability94
53 / 100

Mixed profile: strong on profitability, weaker on health.

All 5 axes are computed from data Checked has read.

Health 7
Profitability 100
Solvency 33
Growth 32
Stability 94

Credit advice

verdict per customer and amount

Should this customer buy amount X on invoice? Enter the amount and payment terms, you get an instant GREEN/AMBER/RED verdict, with a suggested ceiling and concrete conditions.

Based on official sources (NBB, CBE, State Gazette). Indicative, not credit advice.

Similar

Similar companies

Comparable size, same sector

Company registry

Company registry (CBE)

Crossroads Bank
Activities
Huisartspraktijken86210Activiteiten van huisartspraktijken86210
Primary activity highlighted.
Names & trade names
Legal nameFR ALTERITAM
Registered office
de Villegaslaan 5 bus 3
1083 Ganshoren, Belgium
Official data from the Crossroads Bank for Enterprises (CBE). Available for every registered company.